Open AccessEvaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC
Author(s) -
İzzet Doğan,
Mustafa Gürbüz,
Nail Paksoy,
Ferhat Ferhatoğlu,
Sezai Vatansever,
Pınar Saip,
Ahmet Demirkazık,
Adnan Aydıner
Publication year - 2022
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000030188
Subject(s) - medicine , anaplastic lymphoma kinase , oncology , alk inhibitor , pathological , crizotinib , lung cancer , gastroenterology , malignant pleural effusion